Home > > > Report Detail

Global Transdermal Drug Patches Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Publisher Name :
Date: 19-Sep-2022
No. of pages: 127
Inquire Before Buying

Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Transdermal Drug Patches market is projected to reach US$ 8379.6 million by 2028 from an estimated US$ 6896.4 million in 2022, at a CAGR of 3.3% during 2023 and 2028.

The major players in global Transdermal Drug Patches market include Hisamitsu Pharmaceutical, Johnson & Johnson, Mylan, etc. The top 3 players occupy about 35% shares of the global market. America and Europe are main markets, they occupy about 75% of the global market. Methyl Salicylate-based Patch is the main type, with a share over 15%. Rx Channel is the main application, which holds a share about 90%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Transdermal Drug Patches, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Transdermal Drug Patches.

The Transdermal Drug Patches market size, estimations, and forecasts are provided in terms of sales volume (M Pcs) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Transdermal Drug Patches market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Transdermal Drug Patches manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

- Hisamitsu Pharmaceutical

- Johnson & Johnson

- Novartis

- UCB Pharma

- Mylan

- Teva Pharmaceutical

- Nitto Denko

- Grünenthal

- IBSA Group

- GSK

- Luye Pharma Group

- Pfizer

- Chattem

- Dr Reddy's Laboratories

- Bayer

- Mundipharma

- Endo International

- Beijing Tide Pharmaceutical

Product Type Insights

Global markets are presented by Transdermal Drug Patches type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Transdermal Drug Patches are procured by the manufacturers.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Transdermal Drug Patches Segment by Type

- Methyl Salicylate-based Patch

- Rivastigmine Transdermal Patch

- Fentanyl Transdermal Patch

- Lidocaine Patch

- Diclofenac Patch

- Nicotine Transdermal Patch

- Others

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Transdermal Drug Patches market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Transdermal Drug Patches market.

Transdermal Drug Patches Segment by Application

- Rx Channel

- OTC Channel

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Southeast Asia

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Transdermal Drug Patches market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Drug Patches market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Transdermal Drug Patches and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Transdermal Drug Patches industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Drug Patches

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution

Global Transdermal Drug Patches Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Table of Contents
1 Study Coverage
1.1 Transdermal Drug Patches Product Introduction
1.2 Market by Type
1.2.1 Global Transdermal Drug Patches Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Methyl Salicylate-based Patch
1.2.3 Rivastigmine Transdermal Patch
1.2.4 Fentanyl Transdermal Patch
1.2.5 Lidocaine Patch
1.2.6 Diclofenac Patch
1.2.7 Nicotine Transdermal Patch
1.2.8 Others
1.3 Market by Application
1.3.1 Global Transdermal Drug Patches Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Rx Channel
1.3.3 OTC Channel
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Transdermal Drug Patches Market Size Estimates and Forecasts
2.1.1 Global Transdermal Drug Patches Revenue 2017-2028
2.1.2 Global Transdermal Drug Patches Sales 2017-2028
2.2 Transdermal Drug Patches Market Size by Region: 2022 Versus 2028
2.3 Transdermal Drug Patches Sales by Region (2017-2028)
2.3.1 Global Transdermal Drug Patches Sales by Region: 2017-2022
2.3.2 Global Transdermal Drug Patches Sales Forecast by Region (2023-2028)
2.3.3 Global Transdermal Drug Patches Sales Market Share by Region (2017-2028)
2.4 Transdermal Drug Patches Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Transdermal Drug Patches Revenue by Region: 2017-2022
2.4.2 Global Transdermal Drug Patches Revenue Forecast by Region (2023-2028)
2.4.3 Global Transdermal Drug Patches Revenue Market Share by Region (2017-2028)
3 Global Transdermal Drug Patches by Manufacturers
3.1 Global Top Transdermal Drug Patches Manufacturers by Sales
3.1.1 Global Transdermal Drug Patches Sales by Manufacturer (2017-2022)
3.1.2 Global Transdermal Drug Patches Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Transdermal Drug Patches Manufacturers by Revenue
3.2.1 Global Transdermal Drug Patches Revenue by Manufacturer (2017-2022)
3.2.2 Global Transdermal Drug Patches Revenue Share by Manufacturer (2017-2022)
3.3 Global Transdermal Drug Patches Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Transdermal Drug Patches Manufacturers Covered: Ranking by Revenue
3.4.2 Global Transdermal Drug Patches Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Transdermal Drug Patches Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Transdermal Drug Patches Manufacturing Base Distribution, Product Type
3.5.1 Transdermal Drug Patches Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Transdermal Drug Patches Product Type
3.5.3 Date of International Manufacturers Enter into Transdermal Drug Patches Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Hisamitsu Pharmaceutical
4.1.1 Hisamitsu Pharmaceutical Corporation Information
4.1.2 Hisamitsu Pharmaceutical Description, Business Overview
4.1.3 Hisamitsu Pharmaceutical Transdermal Drug Patches Products Offered
4.1.4 Hisamitsu Pharmaceutical Transdermal Drug Patches Sales, Revenue and Gross Margin (2017-2022)
4.1.5 Hisamitsu Pharmaceutical Transdermal Drug Patches Sales by Product in 2021
4.1.6 Hisamitsu Pharmaceutical Transdermal Drug Patches Sales by Application in 2021
4.1.7 Hisamitsu Pharmaceutical Transdermal Drug Patches Sales by Geographic Area in 2021
4.1.8 Hisamitsu Pharmaceutical Recent Developments
4.2 Johnson & Johnson
4.2.1 Johnson & Johnson Corporation Information
4.2.2 Johnson & Johnson Description, Business Overview
4.2.3 Johnson & Johnson Transdermal Drug Patches Products Offered
4.2.4 Johnson & Johnson Transdermal Drug Patches Sales, Revenue and Gross Margin (2017-2022)
4.2.5 Johnson & Johnson Transdermal Drug Patches Sales by Product in 2021
4.2.6 Johnson & Johnson Transdermal Drug Patches Sales by Application in 2021
4.2.7 Johnson & Johnson Transdermal Drug Patches Sales by Geographic Area in 2021
4.2.8 Johnson & Johnson Recent Developments
4.3 Novartis
4.3.1 Novartis Corporation Information
4.3.2 Novartis Description, Business Overview
4.3.3 Novartis Transdermal Drug Patches Products Offered
4.3.4 Novartis Transdermal Drug Patches Sales, Revenue and Gross Margin (2017-2022)
4.3.5 Novartis Transdermal Drug Patches Sales by Product in 2021
4.3.6 Novartis Transdermal Drug Patches Sales by Application in 2021
4.3.7 Novartis Transdermal Drug Patches Sales by Geographic Area in 2021
4.3.8 Novartis Recent Developments
4.4 UCB Pharma
4.4.1 UCB Pharma Corporation Information
4.4.2 UCB Pharma Description, Business Overview
4.4.3 UCB Pharma Transdermal Drug Patches Products Offered
4.4.4 UCB Pharma Transdermal Drug Patches Sales, Revenue and Gross Margin (2017-2022)
4.4.5 UCB Pharma Transdermal Drug Patches Sales by Product in 2021
4.4.6 UCB Pharma Transdermal Drug Patches Sales by Application in 2021
4.4.7 UCB Pharma Transdermal Drug Patches Sales by Geographic Area in 2021
4.4.8 UCB Pharma Recent Developments
4.5 Mylan
4.5.1 Mylan Corporation Information
4.5.2 Mylan Description, Business Overview
4.5.3 Mylan Transdermal Drug Patches Products Offered
4.5.4 Mylan Transdermal Drug Patches Sales, Revenue and Gross Margin (2017-2022)
4.5.5 Mylan Transdermal Drug Patches Sales by Product in 2021
4.5.6 Mylan Transdermal Drug Patches Sales by Application in 2021
4.5.7 Mylan Transdermal Drug Patches Sales by Geographic Area in 2021
4.5.8 Mylan Recent Developments
4.6 Teva Pharmaceutical
4.6.1 Teva Pharmaceutical Corporation Information
4.6.2 Teva Pharmaceutical Description, Business Overview
4.6.3 Teva Pharmaceutical Transdermal Drug Patches Products Offered
4.6.4 Teva Pharmaceutical Transdermal Drug Patches Sales, Revenue and Gross Margin (2017-2022)
4.6.5 Teva Pharmaceutical Transdermal Drug Patches Sales by Product in 2021
4.6.6 Teva Pharmaceutical Transdermal Drug Patches Sales by Application in 2021
4.6.7 Teva Pharmaceutical Transdermal Drug Patches Sales by Geographic Area in 2021
4.6.8 Teva Pharmaceutical Recent Development
4.7 Nitto Denko
4.7.1 Nitto Denko Corporation Information
4.7.2 Nitto Denko Description, Business Overview
4.7.3 Nitto Denko Transdermal Drug Patches Products Offered
4.7.4 Nitto Denko Transdermal Drug Patches Sales, Revenue and Gross Margin (2017-2022)
4.7.5 Nitto Denko Transdermal Drug Patches Sales by Product in 2021
4.7.6 Nitto Denko Transdermal Drug Patches Sales by Application in 2021
4.7.7 Nitto Denko Transdermal Drug Patches Sales by Geographic Area in 2021
4.7.8 Nitto Denko Recent Development
4.8 Grünenthal
4.8.1 Grünenthal Corporation Information
4.8.2 Grünenthal Description, Business Overview
4.8.3 Grünenthal Transdermal Drug Patches Products Offered
4.8.4 Grünenthal Transdermal Drug Patches Sales, Revenue and Gross Margin (2017-2022)
4.8.5 Grünenthal Transdermal Drug Patches Sales by Product in 2021
4.8.6 Grünenthal Transdermal Drug Patches Sales by Application in 2021
4.8.7 Grünenthal Transdermal Drug Patches Sales by Geographic Area in 2021
4.8.8 Grünenthal Recent Development
4.9 IBSA Group
4.9.1 IBSA Group Corporation Information
4.9.2 IBSA Group Description, Business Overview
4.9.3 IBSA Group Transdermal Drug Patches Products Offered
4.9.4 IBSA Group Transdermal Drug Patches Sales, Revenue and Gross Margin (2017-2022)
4.9.5 IBSA Group Transdermal Drug Patches Sales by Product in 2021
4.9.6 IBSA Group Transdermal Drug Patches Sales by Application in 2021
4.9.7 IBSA Group Transdermal Drug Patches Sales by Geographic Area in 2021
4.9.8 IBSA Group Recent Development
4.10 GSK
4.10.1 GSK Corporation Information
4.10.2 GSK Description, Business Overview
4.10.3 GSK Transdermal Drug Patches Products Offered
4.10.4 GSK Transdermal Drug Patches Sales, Revenue and Gross Margin (2017-2022)
4.10.5 GSK Transdermal Drug Patches Sales by Product in 2021
4.10.6 GSK Transdermal Drug Patches Sales by Application in 2021
4.10.7 GSK Transdermal Drug Patches Sales by Geographic Area in 2021
4.10.8 GSK Recent Development
4.11 Luye Pharma Group
4.11.1 Luye Pharma Group Corporation Information
4.11.2 Luye Pharma Group Description, Business Overview
4.11.3 Luye Pharma Group Transdermal Drug Patches Products Offered
4.11.4 Luye Pharma Group Transdermal Drug Patches Sales, Revenue and Gross Margin (2017-2022)
4.11.5 Luye Pharma Group Transdermal Drug Patches Sales by Product in 2021
4.11.6 Luye Pharma Group Transdermal Drug Patches Sales by Application in 2021
4.11.7 Luye Pharma Group Transdermal Drug Patches Sales by Geographic Area in 2021
4.11.8 Luye Pharma Group Recent Development
4.12 Pfizer
4.12.1 Pfizer Corporation Information
4.12.2 Pfizer Description, Business Overview
4.12.3 Pfizer Transdermal Drug Patches Products Offered
4.12.4 Pfizer Transdermal Drug Patches Sales, Revenue and Gross Margin (2017-2022)
4.12.5 Pfizer Transdermal Drug Patches Sales by Product in 2021
4.12.6 Pfizer Transdermal Drug Patches Sales by Application in 2021
4.12.7 Pfizer Transdermal Drug Patches Sales by Geographic Area in 2021
4.12.8 Pfizer Recent Development
4.13 Chattem
4.13.1 Chattem Corporation Information
4.13.2 Chattem Description, Business Overview
4.13.3 Chattem Transdermal Drug Patches Products Offered
4.13.4 Chattem Transdermal Drug Patches Sales, Revenue and Gross Margin (2017-2022)
4.13.5 Chattem Transdermal Drug Patches Sales by Product in 2021
4.13.6 Chattem Transdermal Drug Patches Sales by Application in 2021
4.13.7 Chattem Transdermal Drug Patches Sales by Geographic Area in 2021
4.13.8 Chattem Recent Development
4.14 Dr Reddy's Laboratories
4.14.1 Dr Reddy's Laboratories Corporation Information
4.14.2 Dr Reddy's Laboratories Description, Business Overview
4.14.3 Dr Reddy's Laboratories Transdermal Drug Patches Products Offered
4.14.4 Dr Reddy's Laboratories Transdermal Drug Patches Sales, Revenue and Gross Margin (2017-2022)
4.14.5 Dr Reddy's Laboratories Transdermal Drug Patches Sales by Product in 2021
4.14.6 Dr Reddy's Laboratories Transdermal Drug Patches Sales by Application in 2021
4.14.7 Dr Reddy's Laboratories Transdermal Drug Patches Sales by Geographic Area in 2021
4.14.8 Dr Reddy's Laboratories Recent Development
4.15 Bayer
4.15.1 Bayer Corporation Information
4.15.2 Bayer Description, Business Overview
4.15.3 Bayer Transdermal Drug Patches Products Offered
4.15.4 Bayer Transdermal Drug Patches Sales, Revenue and Gross Margin (2017-2022)
4.15.5 Bayer Transdermal Drug Patches Sales by Product in 2021
4.15.6 Bayer Transdermal Drug Patches Sales by Application in 2021
4.15.7 Bayer Transdermal Drug Patches Sales by Geographic Area in 2021
4.15.8 Bayer Recent Development
4.16 Mundipharma
4.16.1 Mundipharma Corporation Information
4.16.2 Mundipharma Description, Business Overview
4.16.3 Mundipharma Transdermal Drug Patches Products Offered
4.16.4 Mundipharma Transdermal Drug Patches Sales, Revenue and Gross Margin (2017-2022)
4.16.5 Mundipharma Transdermal Drug Patches Sales by Product in 2021
4.16.6 Mundipharma Transdermal Drug Patches Sales by Application in 2021
4.16.7 Mundipharma Transdermal Drug Patches Sales by Geographic Area in 2021
4.16.8 Mundipharma Recent Development
4.17 Endo International
4.17.1 Endo International Corporation Information
4.17.2 Endo International Description, Business Overview
4.17.3 Endo International Transdermal Drug Patches Products Offered
4.17.4 Endo International Transdermal Drug Patches Sales, Revenue and Gross Margin (2017-2022)
4.17.5 Endo International Transdermal Drug Patches Sales by Product in 2021
4.17.6 Endo International Transdermal Drug Patches Sales by Application in 2021
4.17.7 Endo International Transdermal Drug Patches Sales by Geographic Area in 2021
4.17.8 Endo International Recent Development
4.18 Beijing Tide Pharmaceutical
4.18.1 Beijing Tide Pharmaceutical Corporation Information
4.18.2 Beijing Tide Pharmaceutical Description, Business Overview
4.18.3 Beijing Tide Pharmaceutical Transdermal Drug Patches Products Offered
4.18.4 Beijing Tide Pharmaceutical Transdermal Drug Patches Sales, Revenue and Gross Margin (2017-2022)
4.18.5 Beijing Tide Pharmaceutical Transdermal Drug Patches Sales by Product in 2021
4.18.6 Beijing Tide Pharmaceutical Transdermal Drug Patches Sales by Application in 2021
4.18.7 Beijing Tide Pharmaceutical Transdermal Drug Patches Sales by Geographic Area in 2021
4.18.8 Beijing Tide Pharmaceutical Recent Development
5 Breakdown Data by Type
5.1 Global Transdermal Drug Patches Sales by Type (2017-2028)
5.1.1 Global Transdermal Drug Patches Sales by Type (2017-2022)
5.1.2 Global Transdermal Drug Patches Sales Forecast by Type (2023-2028)
5.1.3 Global Transdermal Drug Patches Sales Market Share by Type (2017-2028)
5.2 Global Transdermal Drug Patches Revenue Forecast by Type (2017-2028)
5.2.1 Global Transdermal Drug Patches Revenue by Type (2017-2022)
5.2.2 Global Transdermal Drug Patches Revenue Forecast by Type (2023-2028)
5.2.3 Global Transdermal Drug Patches Revenue Market Share by Type (2017-2028)
5.3 Transdermal Drug Patches Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Transdermal Drug Patches Sales by Application (2017-2028)
6.1.1 Global Transdermal Drug Patches Sales by Application (2017-2022)
6.1.2 Global Transdermal Drug Patches Sales Forecast by Application (2023-2028)
6.1.3 Global Transdermal Drug Patches Sales Market Share by Application (2017-2028)
6.2 Global Transdermal Drug Patches Revenue Forecast by Application (2017-2028)
6.2.1 Global Transdermal Drug Patches Revenue by Application (2017-2022)
6.2.2 Global Transdermal Drug Patches Revenue Forecast by Application (2023-2028)
6.2.3 Global Transdermal Drug Patches Revenue Market Share by Application (2017-2028)
6.3 Transdermal Drug Patches Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America Transdermal Drug Patches Market Size YoY Growth 2017-2028
7.2 North America Transdermal Drug Patches Market Facts & Figures by Country
7.2.1 North America Transdermal Drug Patches Sales by Country (2017-2028)
7.2.2 North America Transdermal Drug Patches Revenue by Country (2017-2028)
7.3 North America Transdermal Drug Patches Sales by Type
7.4 North America Transdermal Drug Patches Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Transdermal Drug Patches Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Transdermal Drug Patches Market Facts & Figures by Region
8.2.1 Asia-Pacific Transdermal Drug Patches Sales by Region (2017-2028)
8.2.2 Asia-Pacific Transdermal Drug Patches Revenue by Region (2017-2028)
8.3 Asia-Pacific Transdermal Drug Patches Sales by Type
8.4 Asia-Pacific Transdermal Drug Patches Sales by Application
9 Europe
9.1 Europe Transdermal Drug Patches Market Size YoY Growth 2017-2028
9.2 Europe Transdermal Drug Patches Market Facts & Figures by Country
9.2.1 Europe Transdermal Drug Patches Sales by Country (2017-2028)
9.2.2 Europe Transdermal Drug Patches Revenue by Country (2017-2028)
9.3 Europe Transdermal Drug Patches Sales by Type
9.4 Europe Transdermal Drug Patches Sales by Application
10 Latin America
10.1 Latin America Transdermal Drug Patches Market Size YoY Growth 2017-2028
10.2 Latin America Transdermal Drug Patches Market Facts & Figures by Country
10.2.1 Latin America Transdermal Drug Patches Sales by Country (2017-2028)
10.2.2 Latin America Transdermal Drug Patches Revenue by Country (2017-2028)
10.3 Latin America Transdermal Drug Patches Sales by Type
10.4 Latin America Transdermal Drug Patches Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Transdermal Drug Patches Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Transdermal Drug Patches Market Facts & Figures by Country
11.2.1 Middle East and Africa Transdermal Drug Patches Sales by Country (2017-2028)
11.2.2 Middle East and Africa Transdermal Drug Patches Revenue by Country (2017-2028)
11.3 Middle East and Africa Transdermal Drug Patches Sales by Type
11.4 Middle East and Africa Transdermal Drug Patches Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Transdermal Drug Patches Supply Chain Analysis
12.2 Transdermal Drug Patches Key Raw Materials and Upstream Suppliers
12.3 Transdermal Drug Patches Clients Analysis
12.4 Transdermal Drug Patches Sales Channel and Sales Model Analysis
12.4.1 Transdermal Drug Patches Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Transdermal Drug Patches Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Transdermal Drug Patches Distributors
13 Market Dynamics
13.1 Transdermal Drug Patches Industry Trends
13.2 Transdermal Drug Patches Market Drivers
13.3 Transdermal Drug Patches Market Challenges
13.4 Transdermal Drug Patches Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Transdermal Drug Patches Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Manufacturers of Methyl Salicylate-based Patch
Table 3. Major Manufacturers of Rivastigmine Transdermal Patch
Table 4. Major Manufacturers of Fentanyl Transdermal Patch
Table 5. Major Manufacturers of Lidocaine Patch
Table 6. Major Manufacturers of Diclofenac Patch
Table 7. Major Manufacturers of Nicotine Transdermal Patch
Table 8. Major Manufacturers of Others
Table 9. Global Transdermal Drug Patches Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global Transdermal Drug Patches Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
Table 11. Global Transdermal Drug Patches Sales by Region (2017-2022) & (M Pcs)
Table 12. Global Transdermal Drug Patches Sales Forecast by Region (2023-2028) & (M Pcs)
Table 13. Global Transdermal Drug Patches Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Transdermal Drug Patches Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 15. Global Transdermal Drug Patches Sales by Manufacturer (2017-2022) & (M Pcs)
Table 16. Global Transdermal Drug Patches Sales Share by Manufacturer (2017-2022)
Table 17. Transdermal Drug Patches Revenue by Manufacturer (2017-2022) & (US$ Million)
Table 18. Transdermal Drug Patches Revenue Share by Manufacturer (2017-2022)
Table 19. Key Manufacturers Transdermal Drug Patches Price (2017-2022) & (US$/Pc)
Table 20. Ranking of Global Top Transdermal Drug Patches Manufacturers by Revenue (US$ Million) in 2021
Table 21. Global Transdermal Drug Patches Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 22. Global Transdermal Drug Patches by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Transdermal Drug Patches as of 2021)
Table 23. Transdermal Drug Patches Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Transdermal Drug Patches Product Type
Table 25. Date of International Manufacturers Enter into Transdermal Drug Patches Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Hisamitsu Pharmaceutical Corporation Information
Table 28. Hisamitsu Pharmaceutical Description and Business Overview
Table 29. Hisamitsu Pharmaceutical Transdermal Drug Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2017-2022)
Table 30. Hisamitsu Pharmaceutical Transdermal Drug Patches Product
Table 31. Hisamitsu Pharmaceutical Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Product in 2021
Table 32. Hisamitsu Pharmaceutical Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Application in 2021
Table 33. Hisamitsu Pharmaceutical Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Geographic Area in 2021
Table 34. Hisamitsu Pharmaceutical Recent Development
Table 35. Johnson & Johnson Corporation Information
Table 36. Johnson & Johnson Description and Business Overview
Table 37. Johnson & Johnson Transdermal Drug Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2017-2022)
Table 38. Johnson & Johnson Transdermal Drug Patches Product
Table 39. Johnson & Johnson Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Product in 2021
Table 40. Johnson & Johnson Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Application in 2021
Table 41. Johnson & Johnson Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Geographic Area in 2021
Table 42. Johnson & Johnson Recent Development
Table 43. Novartis Corporation Information
Table 44. Novartis Description and Business Overview
Table 45. Novartis Transdermal Drug Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2017-2022)
Table 46. Novartis Transdermal Drug Patches Product
Table 47. Novartis Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Product in 2021
Table 48. Novartis Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Application in 2021
Table 49. Novartis Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Geographic Area in 2021
Table 50. Novartis Recent Development
Table 51. UCB Pharma Corporation Information
Table 52. UCB Pharma Description and Business Overview
Table 53. UCB Pharma Transdermal Drug Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2017-2022)
Table 54. UCB Pharma Transdermal Drug Patches Product
Table 55. UCB Pharma Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Product in 2021
Table 56. UCB Pharma Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Application in 2021
Table 57. UCB Pharma Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Geographic Area in 2021
Table 58. UCB Pharma Recent Development
Table 59. Mylan Corporation Information
Table 60. Mylan Description and Business Overview
Table 61. Mylan Transdermal Drug Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2017-2022)
Table 62. Mylan Transdermal Drug Patches Product
Table 63. Mylan Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Product in 2021
Table 64. Mylan Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Application in 2021
Table 65. Mylan Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Geographic Area in 2021
Table 66. Mylan Recent Development
Table 67. Teva Pharmaceutical Corporation Information
Table 68. Teva Pharmaceutical Description and Business Overview
Table 69. Teva Pharmaceutical Transdermal Drug Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2017-2022)
Table 70. Teva Pharmaceutical Transdermal Drug Patches Product
Table 71. Teva Pharmaceutical Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Product in 2021
Table 72. Teva Pharmaceutical Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Application in 2021
Table 73. Teva Pharmaceutical Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Geographic Area in 2021
Table 74. Nitto Denko Corporation Information
Table 75. Nitto Denko Description and Business Overview
Table 76. Nitto Denko Transdermal Drug Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2017-2022)
Table 77. Nitto Denko Transdermal Drug Patches Product
Table 78. Nitto Denko Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Product in 2021
Table 79. Nitto Denko Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Application in 2021
Table 80. Nitto Denko Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Geographic Area in 2021
Table 81. Grünenthal Corporation Information
Table 82. Grünenthal Description and Business Overview
Table 83. Grünenthal Transdermal Drug Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2017-2022)
Table 84. Grünenthal Transdermal Drug Patches Product
Table 85. Grünenthal Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Product in 2021
Table 86. Grünenthal Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Application in 2021
Table 87. Grünenthal Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Geographic Area in 2021
Table 88. IBSA Group Corporation Information
Table 89. IBSA Group Description and Business Overview
Table 90. IBSA Group Transdermal Drug Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2017-2022)
Table 91. IBSA Group Transdermal Drug Patches Product
Table 92. IBSA Group Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Product in 2021
Table 93. IBSA Group Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Application in 2021
Table 94. IBSA Group Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Geographic Area in 2021
Table 95. GSK Corporation Information
Table 96. GSK Description and Business Overview
Table 97. GSK Transdermal Drug Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2017-2022)
Table 98. GSK Transdermal Drug Patches Product
Table 99. GSK Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Product in 2021
Table 100. GSK Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Application in 2021
Table 101. GSK Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Geographic Area in 2021
Table 102. Luye Pharma Group Corporation Information
Table 103. Luye Pharma Group Description and Business Overview
Table 104. Luye Pharma Group Transdermal Drug Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2017-2022)
Table 105. Luye Pharma Group Transdermal Drug Patches Product
Table 106. Luye Pharma Group Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Product in 2021
Table 107. Luye Pharma Group Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Application in 2021
Table 108. Luye Pharma Group Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Geographic Area in 2021
Table 109. Pfizer Corporation Information
Table 110. Pfizer Description and Business Overview
Table 111. Pfizer Transdermal Drug Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2017-2022)
Table 112. Pfizer Transdermal Drug Patches Product
Table 113. Pfizer Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Product in 2021
Table 114. Pfizer Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Application in 2021
Table 115. Pfizer Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Geographic Area in 2021
Table 116. Chattem Corporation Information
Table 117. Chattem Description and Business Overview
Table 118. Chattem Transdermal Drug Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2017-2022)
Table 119. Chattem Transdermal Drug Patches Product
Table 120. Chattem Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Product in 2021
Table 121. Chattem Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Application in 2021
Table 122. Chattem Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Geographic Area in 2021
Table 123. Dr Reddy's Laboratories Corporation Information
Table 124. Dr Reddy's Laboratories Description and Business Overview
Table 125. Dr Reddy's Laboratories Transdermal Drug Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2017-2022)
Table 126. Dr Reddy's Laboratories Transdermal Drug Patches Product
Table 127. Dr Reddy's Laboratories Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Product in 2021
Table 128. Dr Reddy's Laboratories Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Application in 2021
Table 129. Dr Reddy's Laboratories Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Geographic Area in 2021
Table 130. Bayer Corporation Information
Table 131. Bayer Description and Business Overview
Table 132. Bayer Transdermal Drug Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2017-2022)
Table 133. Bayer Transdermal Drug Patches Product
Table 134. Bayer Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Product in 2021
Table 135. Bayer Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Application in 2021
Table 136. Bayer Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Geographic Area in 2021
Table 137. Mundipharma Corporation Information
Table 138. Mundipharma Description and Business Overview
Table 139. Mundipharma Transdermal Drug Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2017-2022)
Table 140. Mundipharma Transdermal Drug Patches Product
Table 141. Mundipharma Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Product in 2021
Table 142. Mundipharma Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Application in 2021
Table 143. Mundipharma Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Geographic Area in 2021
Table 144. Endo International Corporation Information
Table 145. Endo International Description and Business Overview
Table 146. Endo International Transdermal Drug Patches Sales (M Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2017-2022)
Table 147. Endo International Transdermal Drug Patches Product
Table 148. Endo International Transdermal Drug Patches Sales Proportion of Transdermal Drug Patches by Product in 2021
Table 149. Endo International Transdermal Drug Patches Sales Proportion
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs